SCHEMBL7212713

SCHEMBL7212713

COc1cc(C2(c3cc(OC)c(OC)c(OC)c3)OCCO2)cc(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.45
MAPT P10636 5/20 0.43
CYP3A4 P08684 3/20 0.43
CA9 Q16790 1/20 0.43
PTAFR P25105 2/20 0.43
PTGS2 P35354 1/20 0.41
PTPN1 P18031 1/20 0.41
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18287910 0.78 MAOA (0.50) ACHECA9ALDH1A1MEN1KMT2A
SCHEMBL9337958 0.75 MAPT (0.40) ACHEMAPTCYP3A4CA9PTAFR
SCHEMBL8563574 0.74 MAPT (0.44) ACHEMAPTCYP3A4CA9PTAFR
SCHEMBL18287909 0.72 MAOA (0.47) ACHECA9ALDH1A1MEN1KMT2A
SCHEMBL9729169 0.71 ALDH1A1 (0.36) MAPTCYP3A4CA9PTAFRPTGS2
SCHEMBL9338353 0.71 L3MBTL1 (0.37) ACHEMAPTCA9PTAFRKDM4E
SCHEMBL28893222 0.69 MAPT (0.54) ACHEMAPTCYP3A4CA9PTAFR
SCHEMBL9719037 0.69 MAPT (0.54) ACHEMAPTCYP3A4CA9PTAFR
SCHEMBL9338356 0.69 KDM4E (0.37) ACHEMAPTCYP3A4CA9PTAFR
SCHEMBL9721261 0.68 LMNA (0.41) ACHEMAPTCYP3A4CA9PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082199-A2 PLATELET-ACTIVATING FACTOR ANTAGONISTS AS ANALGESIC, ANTI-INFLAMMATORY, UTERINE CONTRACTION INHIBITING, AND ANTI-TUMOR AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-10-09 WO claimed